As of 2024-07-27, the Relative Valuation of Pfizer Inc (PFE) is (9.27) USD. This relative valuation is based on P/E multiples. With the latest stock price at 30.77 USD, the upside of Pfizer Inc based on Relative Valuation is -130.1%.
The range of the Relative Valuation is (23.48) - 10.27 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.5x - 32.6x | 30.7x |
| Forward P/E multiples | 20.6x - 30.5x | 25.6x |
| Fair Price | (23.48) - 10.27 | (9.27) |
| Upside | -176.3% - -66.6% | -130.1% |
| Date | P/E |
| 2024-07-26 | -34.75 |
| 2024-07-25 | -34.08 |
| 2024-07-24 | -33.85 |
| 2024-07-23 | -33.31 |
| 2024-07-22 | -33.43 |
| 2024-07-19 | -33.84 |
| 2024-07-18 | -33.55 |
| 2024-07-17 | -33.91 |
| 2024-07-16 | -33.31 |
| 2024-07-15 | -32.86 |
| 2024-07-12 | -32.66 |
| 2024-07-11 | -32.36 |
| 2024-07-10 | -32.01 |
| 2024-07-09 | -31.30 |
| 2024-07-08 | -31.54 |
| 2024-07-05 | -31.68 |
| 2024-07-03 | -31.28 |
| 2024-07-02 | -31.43 |
| 2024-07-01 | -31.87 |
| 2024-06-28 | -31.60 |
| 2024-06-27 | -31.39 |
| 2024-06-26 | -30.96 |
| 2024-06-25 | -31.61 |
| 2024-06-24 | -32.03 |
| 2024-06-21 | -31.33 |
| 2024-06-20 | -31.33 |
| 2024-06-18 | -30.95 |
| 2024-06-17 | -30.47 |
| 2024-06-14 | -31.09 |
| 2024-06-13 | -31.22 |
| 2024-06-12 | -31.24 |
| 2024-06-11 | -31.65 |
| 2024-06-10 | -31.70 |
| 2024-06-07 | -32.27 |
| 2024-06-06 | -32.52 |
| 2024-06-05 | -33.37 |
| 2024-06-04 | -33.30 |
| 2024-06-03 | -33.10 |
| 2024-05-31 | -32.36 |
| 2024-05-30 | -31.84 |
| 2024-05-29 | -31.42 |
| 2024-05-28 | -31.96 |
| 2024-05-24 | -32.61 |
| 2024-05-23 | -32.40 |
| 2024-05-22 | -33.43 |
| 2024-05-21 | -32.25 |
| 2024-05-20 | -32.22 |
| 2024-05-17 | -32.34 |
| 2024-05-16 | -32.66 |
| 2024-05-15 | -32.55 |